- US12195524utility2025Multi-specific Antigen Binding Molecules Targeting HIV and Methods of Use0 cites
- US12187734utility2025Substituted Pyridotriazine Compounds and Uses Thereof0 cites
- US12187753utility2025Therapeutics Compounds for HIV Virus Infection0 cites
- US12180197utility2024GLP-1R Modulating Compounds0 cites
- US12180217utility2024Compounds and Methods for Treatment of Viral Infections0 cites
- US12161625utility2024Substituted Pyrrolizine Compounds and Uses Thereof0 cites
- US12162844utility2024MCL-1 Inhibitors0 cites
- US12162896utility2024Salts and Polymorphs of Certain MCL-1 Inhibitors0 cites
- US12139474utility2024LPA Receptor Antagonists and Uses Thereof0 cites
- US12121511utility2024GLP-1R Modulating Compounds0 cites
- US12121529utility2024Nucleoside Phosphoramidate Prodrugs0 cites
- US12122764utility2024IKAROS Zinc Finger Family Degraders and Uses Thereof0 cites
- US12122765utility2024Methods and Intermediates for Preparing Therapeutic Compounds0 cites
- US12122776utility2024Tetracyclic Compounds and Uses Thereof0 cites
- US12116380utility2024Phospholipid Compounds and Methods of Making and Using the Same0 cites
- US12110294utility2024CD73 Compounds0 cites
- US12110305utility2024Prodrugs of Phosphonamide Nucleotide Analogues and Their Pharmaceutical Use0 cites
- US12102625utility2024Solid Forms of FXR Agonists0 cites
- US12102677utility2024Methods of Identifying HIV Patients Sensitive to Therapy with GP120 V3 Glycan-directed Antibodies0 cites
- US12091404utility2024GLP-1R Modulating Compounds0 cites